Hardware Podcasts

Why FDA is Prioritizing Clinical Decision Support Software & Why You Should Care

Global Medical Device Podcast · 2 Dec 2021 · 31m · Episode 238

What this episode covers

Mike Drues of Vascular Sciences explains the FDA's new priority to finalize guidance on Clinical Decision Support (CDS) software, which provides patient-specific information to enhance healthcare. He details how the FDA currently uses enforcement discretion for low-risk CDS tools, such as telehealth platforms, but warns that this status is fragile and could change if inaccurate information leads to patient harm. Drues outlines four specific boundaries that would trigger FDA regulation, including software that analyzes medical images or provides diagnosis recommendations, and emphasizes the critical need for rigorous validation, usability testing, and data privacy measures even in the absence of immediate regulatory oversight.

Most relevant to

early-stage companies

Topics

Mentioned

Companies
Green Light guru, Vascular Sciences, Theranos
Products
WebMD

Related episodes from other shows

Other shows on the same ground, closest first.

  • Let's Combinate · 1h 03m

    021 - "Options" with Karandeep Singh Badwal

    Karandeep Singh Badwal, a QA/RA consultant and host of The MedTech Podcast, explains how defining 'intended use' determines whether a product is a regulated medical device or unregulated software, a critical distinction for startups. He details the specific regulatory challenges of Software as a Medical Device (SaMD), including cybersecurity, GDPR compliance, and the impact of the EU MDR on software classification. Badwal also discusses the strategic advantages for UK software companies post-Brexit, where they can still self-certify as Class 1 devices while EU counterparts face stricter notified body audits.

    Validation & product-market fitQuality & yield
    9 chapters

  • Embedded.fm · 1h 09m

    67: Software for Things That Can Kill People

    Hosts Chris White and Elecia White discuss the rigorous regulatory processes for safety-critical software, drawing on their experiences with the FAA (DO-178B) and FDA (510k, PMA) for medical devices and avionics. They explain how hazard analysis determines certification levels, the necessity of extensive documentation and traceability, and the tension between agile development and waterfall compliance. The conversation highlights the ethical responsibility of engineers to push back against unsafe deadlines, the use of hardware compartmentalization (FPGAs, voting systems) to ensure safety, and the legal liabilities associated with product failures.

    Certification & complianceMechanical engineering
    8 chapters

  • Let's Combinate · 34m

    172 - Regulatory AI Innovations, Drugs@FDA Database, Regulatory Intelligence Strategies, Human Factors Insights, and Smarter Submission Approaches with Doug Mead

    Doug Mead, founder of CP Pathways and Rhizome AI, explains how his company uses AI to search the FDA's Drugs@FDA database, enabling faster regulatory intelligence for combination products. He details the transition from manual Google searches to a specialized tool that handles OCR and semantic search to interpret review memos, human factors data, and Type C meeting minutes. Mead highlights the value of understanding FDA precedents for products like auto-injectors and on-body injectors, while noting limitations such as redacted data and unpublished supplement reviews.

    Connected products & IoTCertification & compliance
    7 chapters

  • The Pragmatic Embedded Podcast · 33m

    How to Speed Up Safety Critical Processes

    Jeff Gable and Luca Njani discuss strategies to accelerate safety-critical development in medical devices, automotive, and aerospace without compromising quality. They argue that reducing scope for initial releases and automating documentation using modern tools like Jama and Matrix significantly shortens cycle times. The hosts emphasize that modern regulatory guidance, such as the FDA's Computer System Assurance, supports streamlined validation processes, allowing teams to iterate faster and uncover defects earlier.

    Medical & health devicesDesign for manufacturing & NPI
    7 chapters

  • Let's Combinate · 36m

    104 -New FDA Guidance, HF vs. Design Validation, Critical Tasks & Pre-IND HF Studies with Sara McNew

    Sara McNew, Chief Scientific Officer at Design Science, discusses the new FDA Guidance on Human Factors for Combination Products, clarifying the distinction between human factors validation and broader design validation. She explains that pre-IND studies must demonstrate that clinical trial participants can use the device correctly to ensure accurate pharmacokinetic data, requiring a hybrid of formative and summative rigor. McNew details how critical task definitions now include administration and dosing errors, not just serious harm, and emphasizes the importance of submitting comprehensive Use Related Risk Assessments (URRA) alongside HF summaries.

    Medical & health devicesCertification & compliance
    9 chapters

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Global Medical Device Podcast. The episode itself belongs to its publisher.